Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Al‐Janabi
Risankizumab vs. Ustekinumab for Plaque Psoriasis
British Journal of Dermatology
Dermatology
Medicine
Risankizumab Versus Ustekinumab for Plaque Psoriasis: A Critical Appraisal
British Journal of Dermatology
Dermatology
Medicine
Related publications
Risankizumab for the Treatment of Plaque Psoriasis in Adults
Prescriber
Pharmacology
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
JAMA Dermatology
Dermatology
Medicine
Meta‐analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority
Clinical Pharmacology and Therapeutics
Pharmacology
Urticarial Reaction to Ustekinumab During the Treatment of Plaque Psoriasis in a Hepatitis C-Positive Patient
Drug Safety - Case Reports
Pharmacology
Psoriatic Skin Molecular and Histopathological Profiles Following Treatment With Risankizumab Versus Ustekinumab
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Psoriasis: Therapie Mit Ustekinumab Ist Langzeitig Erfolgreich
hautnah dermatologie
Infliximab for the Treatment of Plaque Psoriasis
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Dimethyl Fumarate for the Treatment of Plaque Psoriasis
Prescriber
Pharmacology